BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 2557873)

  • 21. Neocortical changes in Parkinson's disease, revisited.
    Sugiyama H; Hainfellner JA; Yoshimura M; Budka H
    Clin Neuropathol; 1994; 13(2):55-9. PubMed ID: 8205726
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Diffuse Lewy body disease].
    Yoshimura M
    Rinsho Shinkeigaku; 1997 Dec; 37(12):1134-6. PubMed ID: 9577669
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuropathology of human sympathetic autonomic ganglia.
    Schmidt RE
    Microsc Res Tech; 1996 Oct; 35(2):107-21. PubMed ID: 8923446
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Lewy body in Parkinson's disease.
    Forno LS
    Adv Neurol; 1987; 45():35-43. PubMed ID: 3030070
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiac sympathetic denervation precedes neuronal loss in the sympathetic ganglia in Lewy body disease.
    Orimo S; Amino T; Itoh Y; Takahashi A; Kojo T; Uchihara T; Tsuchiya K; Mori F; Wakabayashi K; Takahashi H
    Acta Neuropathol; 2005 Jun; 109(6):583-8. PubMed ID: 15933869
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Silver stainings distinguish Lewy bodies and glial cytoplasmic inclusions: comparison between Gallyas-Braak and Campbell-Switzer methods.
    Uchihara T; Nakamura A; Mochizuki Y; Hayashi M; Orimo S; Isozaki E; Mizutani T
    Acta Neuropathol; 2005 Sep; 110(3):255-60. PubMed ID: 16003542
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuropathology of autonomic nervous system in Parkinson's disease.
    Wakabayashi K; Takahashi H
    Eur Neurol; 1997; 38 Suppl 2():2-7. PubMed ID: 9387796
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Parkinson's disease: an immunohistochemical study of Lewy body-containing neurons in the enteric nervous system.
    Wakabayashi K; Takahashi H; Ohama E; Ikuta F
    Acta Neuropathol; 1990; 79(6):581-3. PubMed ID: 1972853
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Lewy bodies, a misleading marker for Parkinson's disease?].
    Duyckaerts C; Hauw JJ
    Bull Acad Natl Med; 2003; 187(2):277-92; discussion 292-3. PubMed ID: 14556441
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lewy bodies of Parkinson's disease. Immune electron microscopic demonstration of neurofilament antigens in constituent filaments.
    Pappolla MA
    Arch Pathol Lab Med; 1986 Dec; 110(12):1160-3. PubMed ID: 3022672
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Parkinson's disease, dementia with Lewy bodies, multiple system atrophy and alpha-synuclein].
    Iwatsubo T
    Rinsho Shinkeigaku; 1999 Dec; 39(12):1285-6. PubMed ID: 10791099
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gastric alpha-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology.
    Braak H; de Vos RA; Bohl J; Del Tredici K
    Neurosci Lett; 2006 Mar; 396(1):67-72. PubMed ID: 16330147
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alpha-synuclein pathology in Parkinson's and Alzheimer's disease brain: incidence and topographic distribution--a pilot study.
    Jellinger KA
    Acta Neuropathol; 2003 Sep; 106(3):191-201. PubMed ID: 12845452
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neurofilament mRNA is reduced in Parkinson's disease substantia nigra pars compacta neurons.
    Hill WD; Arai M; Cohen JA; Trojanowski JQ
    J Comp Neurol; 1993 Mar; 329(3):328-36. PubMed ID: 8459049
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The frequency of Lewy bodies in a consecutive autopsy series.
    Lindboe CF; Hansen HB
    Clin Neuropathol; 1998; 17(4):204-9. PubMed ID: 9707335
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Diffuse Lewy body disease searched out from 114 patients with parkinsonism].
    Jin K; Sato N; Hisanaga K; Suzuki H; Mochizuki H
    Rinsho Shinkeigaku; 2000 Apr; 40(4):329-33. PubMed ID: 10967648
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Parkinson's disease: the presence of Lewy bodies in Auerbach's and Meissner's plexuses.
    Wakabayashi K; Takahashi H; Takeda S; Ohama E; Ikuta F
    Acta Neuropathol; 1988; 76(3):217-221. PubMed ID: 2850698
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The progression of pathology in longitudinally followed patients with Parkinson's disease.
    Halliday G; Hely M; Reid W; Morris J
    Acta Neuropathol; 2008 Apr; 115(4):409-15. PubMed ID: 18231798
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gene expression profiling of Lewy body-bearing neurons in Parkinson's disease.
    Lu L; Neff F; Alvarez-Fischer D; Henze C; Xie Y; Oertel WH; Schlegel J; Hartmann A
    Exp Neurol; 2005 Sep; 195(1):27-39. PubMed ID: 15944136
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lewy bodies in progressive supranuclear palsy represent an independent disease process.
    Uchikado H; DelleDonne A; Ahmed Z; Dickson DW
    J Neuropathol Exp Neurol; 2006 Apr; 65(4):387-95. PubMed ID: 16691119
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.